Omni Peptides
Ipamorelin
Couldn't load pickup availability
↑ GH/IGF-1, better sleep & recovery, body recomposition
Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue (GHS) that functions as a potent agonist of the ghrelin receptor (GHS-R1a). This research compound has attracted substantial scientific interest due to its ability to stimulate pulsatile endogenous growth hormone (GH) release from the anterior pituitary with minimal impact on other hormones such as prolactin, cortisol, or adrenocorticotropic hormone (ACTH). Preliminary and advanced preclinical studies indicate that Ipamorelin may promote lipolysis, support lean body mass, enhance recovery processes, and exhibit favorable pharmacokinetic properties including high selectivity and stability. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of GH axis modulation, body composition, tissue repair, and age-related endocrine changes. As a research-grade compound, Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its clean pharmacological profile, lack of significant appetite stimulation compared to other GHS compounds, and utility in advancing understanding of selective ghrelin receptor agonism in anabolic and metabolic research.
Research Applications
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.
— About this compound
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue.
Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue (GHS) that functions as a potent agonist of the ghrelin receptor (GHS-R1a). This research compound has attracted substantial scientific interest due to its ability to stimulate pulsatile endogenous growth hormone (GH) release from the anterior pituitary with minimal impact on other hormones such as prolactin, cortisol, or adrenocorticotropic hormone (ACTH). Preliminary and advanced preclinical studies indicate that Ipamorelin may promote lipolysis, support lean body mass, enhance recovery processes, and exhibit favorable pharmacokinetic properties including high selectivity and stability. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of GH axis modulation, body composition, tissue repair, and age-related endocrine changes. As a research-grade compound, Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its clean pharmacological profile, lack of significant appetite stimulation compared to other GHS compounds, and utility in advancing understanding of selective ghrelin receptor agonism in anabolic and metabolic research.
Research Applications
Where researchers apply it.
— Verified & Documented
Every vial is backed by a Certificate of Analysis.
Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.
Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.